Danielle Hanke
Student
Doctor of Philosophy in Pharmaceutical Sciences (PhD)
Pharmaceutical Sciences covers research areas of nanomedicine, drug delivery; drug metabolism, pharmacokinetics and toxicology; pharmacogenomics and pharmacogenetics; diabetes, cardiovascular and molecular pharmacology; neuropharmacology; cancer pharmacology; pharmaceutical health outcomes and pharmacotherapeutics; and pharmaceutical education.
| Name | Research Interests |
|---|---|
| Beedle, Aaron | |
| Cairns, Brian | electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders; Electrophysiology, Headache, Neuropharmacology, Oro-Facial Pain, Pain, Pain mechanisms, Peripheral analgesics, Sex-related differences, Temporomandibular disorders |
| Chang, Thomas | Nuclear receptors are evolutionarily-related DNA-binding transcription factors that regulate the expression of a broad array of genes involved in various biological processes |
| Cheng, Miffy | nanomedicine; gene therapy to combat chronic diseases; nanomedicine, gene therapy to combat chronic diseases |
| Conklin, Annalijn | Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology; women's health; Health Equity; Chronic Diseases in Elderly; Obesity; CVD risk factors; healthy ageing; food and nutrition policy; Indigenous health; Community Health / Public Health; disease management evaluation; healthcare quality improvement; Social Determinants of Dietary and Metabolic Disorders, Social nutritional epidemiology, Women's Health, Health equity, Chronic Diseases in Elderly, Obesity, CVD risk factors, Healthy ageing, Food and nutrition policy, Indigenous health, Community Health / Public Health, Disease management evaluation, Healthcare quality improvement |
| Coughtrie, Michael | Drug metabolizing enzymes |
| Cragg, Jacquelyn | data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease; data science, open science, causal inference, drug effectiveness, drug safety, epidemiology, neuro-epidemiology, neurological diseases, spinal cord injury, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Parkinson’s disease |
| De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
| Finbloom, Joel | nanomedicine; Chemical Biology; drug delivery; Pharmaceutical Sciences; Infectious disease; Bacterial Biofilms; Microbiome; Probiotics; Antibiotic resistance; Nanomedicine, Chemical Biology, Drug Delivery, Pharmaceutical Sciences, Infectious Disease, Bacterial Biofilms, Microbiome, Probiotics, Antibiotic Resistance |
| Frankel, Adam | Protein Biochemistry; arginine methylation; Histones; Nucleosomes; post-translational modifications; Biological and Biochemical Mechanisms; Organic Molecules and Biomolecules; Bioactive Molecules; Proteins; Chemical Biology; drug discovery; Target Engagement; Amino acids; Protein biochemistry, Arginine methylation, Histones, Nucleosomes, Post-translational modifications, Biological and Biochemical Mechanisms, Organic Molecules and Biomolecules, Bioactive Molecules, Proteins, Chemical biology, Drug discovery, Target engagement, Amino acids |
| Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
| Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
| Hedtrich, Sarah | Nanotechnology; Bioengineering Human (Disease) Models; Gene Therapy; Human Epithelia; Next-Generation Therapies for Inflammatory and Genetic Diseases of Human Epithelia; Topical drug delivery and Nanomedicine; Nanotechnology, Bioengineering Human (Disease) Models, Gene Therapy, Human Epithelia, Next-Generation Therapies for Inflammatory and Genetic Diseases of Human Epithelia, Topical Drug Delivery and Nanomedicine |
| Jarvis-Selinger, Sandra | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
| Johnson, Kate | Health economics; Health outcomes; Epidemiology; Health Economics, Health Outcomes, Epidemiology |
| Krentz, Nicole | Diabetes; Developmental biology; Genetics; Diabetes, Developmental Biology, Genetics |
| Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
| Lalji, Fawziah | Pharmacoepidemiology; Infectious diseases; Immunization; Antibiotics and Resistance; Vaccine preventable diseases; Pharmacoepidemiology, Infectious Diseases, Immunization, Antibiotics and Resistance, Vaccine preventable diseases |
| Li, Shyh-Dar | biopharmaceutics; drug delivery; nanomedicine; pharmaceutics; Gene delivery and therapy; Regenerative medicine; Localized drug delivery; Biopharmaceutics, Drug delivery, Nanomedicine, Pharmaceutics, Gene delivery and therapy, Regenerative medicine, Localized drug delivery |
| Loewen, Peter | atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making; Atrial fibrillation, Pharmacoepidemiology, Thrombosis and Embolism, Adherence to medication, Cardiovascular Diseases, Arrhythmia, Heart Failure, Stroke, Health Care Technologies, Professional Practices, Hematology, Decision Making, Clinical prediction rules, Hospital pharmacy practice, Knowledge translation of evidence to patient care, Patient complexiometry, Patient decision aids, Patient education, Pharmacy practice, Prediction of stroke and bleeding in atrial fibrillation patients, Quality of care, quality drug therapy, Shared decision-making, Stroke prevention therapy, Use of mobile technology for clinical decision-making |
| Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
| Maharaj, Anil | Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology; Pharmacometrics, Pharmacokinetics/Pharmacodynamics, Obstetric and Pediatric Pharmacology |
| McCormack, James | Knowledge translation and evidence-based practice; Knowledge translation and evidence-based practice |
| Nislow, Corey | genomics; Genetics; drug discovery; Biotechnology; Space Biology; Genomics, genetics, Drug Discovery, Biotechnology, Space Biology |
| Page, Brent | Cell Signaling and Cancer; Cancer; Cell signaling; Chemical Biology; Drug development; Drug Discovery, Design and Delivery; Medicinal Chemistry; Target Engagement; Cell Signaling and Cancer, Cancer, Cell Signaling, Chemical Biology, Drug Development, Drug Discovery, Design and Delivery, Medicinal Chemistry, Target Engagement |
